Sticking to KRAS-related pancreatic cancer research not only contributes to a deeper understanding of the pathobiology of pancreatic cancer but can also promote the development of treatment strategies, the refinement of individualized therapy, and the advancement of translational medicine. Here, KRAS is linked to familial pancreatic carcinoma.